MaaT Pharma to Present Promising Clinical Data for Lead Therapeutic Candidate MaaT013 at 48th EBMT Annual Meeting
Data from 76 patients with acute Graft-vs-Host Disease (aGvHD) treated with MaaT013 will be presented. Oral presentation will highlight MaaT013's potential in improving survival outcome for
Source: finanznachrichten.de